# What soreness and a later X-ray can each tell you *Regenerative Therapy Phoenix | Blood and Tissue Care and X-Rays* > Regenerative therapy Phoenix options use blood or tissue; learn why less soreness and a different-looking later X-ray are separate results. ## What to notice before you look at the X-ray Some mornings, a joint feels stiff for the first few steps. It may loosen enough for breakfast and errands. Wear can appear on an X-ray while you feel fairly good. A joint can also hurt badly despite only mild wear on the X-ray. Soreness and an X-ray don't answer the same question. The X-ray shows the bones and the gap at the joint. It can't show whether stairs hurt today or the ache woke you. Your exam adds swelling, tender spots, strength, and movement. What you can do each day completes the information your doctor needs. ## What to track during an ordinary week Choose a usual task before starting physical therapy, medicine, or a procedure. It might be standing from a chair, walking downhill, or reaching overhead. Mark the moment soreness begins. Also note when it settles after you stop. That gives your doctor a useful starting point. Repeat the same task after the named treatment begins. Use the same walk, stairs, or reach at about the same effort. Compare how far you get and how long the soreness lasts afterward. Don't push through sharp pain to make the test harder. Similar tasks on usual days will show more than one unusually good or bad day. Poor sleep or extra activity can make soreness worse for a while. That doesn't mean you imagined the pain. Look for the same improvement across several usual days before calling the treatment helpful. ## What to ask when a scan looks worn Ask whether the exam and X-ray suggest the same cause. Wear on an X-ray doesn't decide how much care you need. Strength, balance, swelling, sleep, and walking limits matter too. Surgery may need discussion when everyday tasks keep getting harder, but the X-ray can't decide by itself. Name the result you want before choosing care. Ask, “Do you expect less soreness, easier walking, or a later scan that looks different?” If a scan may change, ask which part should look different. New cartilage and less swelling aren't the same finding. Also ask when another scan would be useful. While you decide, keep your notes and use movement that doesn't sharpen the soreness. ## Sources 1. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 2. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. 3. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other. Eckstein F, et al. — [Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.](https://pubmed.ncbi.nlm.nih.gov/33962962/). *Annals of the rheumatic diseases*, 2021. DOI: 10.1136/annrheumdis-2020-219181. 4. A systematic review of the discordance between clinical and radiographic knee osteoarthritis: many people with severe-looking x-rays have little pain, and many with disabling pain have modest radiographic change. This is the reason a post-treatment scan is a poor proxy for how someone feels, in either direction. Bedson J, et al. — [The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature.](https://pubmed.ncbi.nlm.nih.gov/18764949/). *BMC musculoskeletal disorders*, 2008. DOI: 10.1186/1471-2474-9-116. 5. A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it. Sadeghirad B, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. ## What to ask QC Kinetix about your soreness QC Kinetix medical providers, meaning clinicians who examine joints, discuss non-surgical regenerative treatments made with your blood or tissue. Book a free consultation: --- Clear answers for a sore joint. Clear answers about knee, hip, or shoulder soreness in Phoenix, including home steps, reasons to seek care, non-surgical choices, and local clinic access. Clear information about why joints ache, safer home steps, times to seek care, and treatment choices around Phoenix. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including Banner Estrella, Scottsdale, Peoria and Chandler, and the clinic business may benefit when a reader books a consultation. © 2026 Phoenix Joint Ledger. General education only, not medical advice for an individual joint.